Announcements Trials
Browse Landscape

Phase

Phase NA 11Phase 2 6Phase 3 2Phase 4 1Phase 1 1

Status

Unknown 2Recruiting 1Enrolling by invitation 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 320INDUSTRY 73NIH 71NETWORK 7OTHER_GOV 6UNKNOWN 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 150Thoracic 82Breast 76Gynecologic 34Lymphoid 30Head & Neck 26Other hematologic neoplasm 17Genitourinary 17Dermatologic 13Sarcoma 11Tumor-Agnostic 8CNS 7Other solid neoplasm 6Endocrine 6Plasma cell 5NET 5Myeloid 5Classical hematology 3Other neoplasm 1Other 1

Conditions

Neuroendocrine Tumors 4Parkinson Disease 1Neoplasms 1Hypersensitivity 1Gastro-enteropancreatic neuroendocrine tumor 1Adrenocortical Carcinoma 1Adenoma, Islet Cell 1

Interventions

pembrolizumab 1lenvatinib 1Tomography, Emission-Computed, Single-Photon 1PM 01183 1Irinotecan 1Iodine-124 1Iodine-123 1Injections 1Etoposide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × OTHER_GOV × Endocrine × Clear all
NCT07404176 2026-02-11

TENET

Tata Memorial Hospital

Phase 2 Recruiting
20 enrolled
EndocrineNET

Neoplasms, Neuroendocrine Tumors

NCT05036434 2026-01-23

ACCOMPLISH

National Cancer Center, Korea

Phase 2 Active not recruiting
30 enrolled
Endocrine

Adrenocortical Carcinoma

NCT07121478 2025-10-01

Patients With High-grade Pancreatic Neuroendocrine Tumors

National Cancer Center, Korea

Phase 2 Enrolling by invitation
46 enrolled
EndocrineNET

Adenoma, Islet Cell, Neuroendocrine Tumors

NCT01673906 2025-06-24

68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours

Azienda USL Reggio Emilia - IRCCS

Phase 2 Completed
142 enrolled
EndocrineNET

Hypersensitivity, Neuroendocrine Tumors

NCT03963193 2019-05-24

Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type

Henan Cancer Hospital

Phase 2 Unknown
112 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor

NCT01931488 2013-08-29

124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors.

Tel-Aviv Sourasky Medical Center

Phase 2 Unknown
40 enrolled
EndocrineNET

Parkinson Disease, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡